6515--Request for Information Name Brand GENDX Reagent Or Equal
ID: 36C26325Q0012Type: Sources Sought
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNETWORK CONTRACT OFFICE 23 (36C263)Saint Paul, MN, 55101, USA

NAICS

Medicinal and Botanical Manufacturing (325411)

PSC

MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES (6515)

Original Source

https://sam.gov/opp/dfdd3fdb484e4fad88ea5cc9b2859533/view
Timeline
    Description

    The Department of Veterans Affairs (VA) is seeking qualified businesses to provide GenDx NSG Reagents for laboratory use, either as brand-name or equal products. This request for information aims to identify potential sources capable of supplying next-generation sequencing (NGS) reagent kits compatible with the Illumina MiSeq instrument, which are crucial for identifying human leukocyte antigen alleles in compliance with Clinical Laboratory Improvement Act (CLIA) standards. Interested parties must respond by 08:00 AM CST on September 25, 2024, providing detailed company information and relevant certifications to Contracting Specialist Christi Melendez at Christi.Melendez@va.gov. This opportunity is part of the VA's commitment to maintaining high standards in laboratory operations and ensuring the availability of essential reagents for patient testing and research.

    Point(s) of Contact
    Christi MelendezContracting Specialist
    (320) 255-6320
    Christi.Melendez@va.gov
    Files
    Title
    Posted
    36C26325Q0012.docx
    The document is a Sources Sought Notice issued by the Department of Veterans Affairs (VA) Network 23, seeking qualified businesses to provide GenDx reagents, either as brand-name or equal products. This notice invites responses from interested sources by September 25, 2024, and emphasizes that it is not a solicitation for a contract—but an opportunity to gauge market capabilities. Potential responders must provide specific information, including their company details, type of products offered, business size classification, and relevant certification from the manufacturer. The VA aims to utilize the gathered responses for market research and potential future acquisitions while reiterating that there is no obligation for contract award or reimbursement for costs incurred. Furthermore, respondents are cautioned against including sensitive information in their submissions, and the government will utilize non-proprietary information as required. This document illustrates the VA's commitment to sourcing necessary lab reagents and reflects standard governmental procurement procedures in soliciting information from potential suppliers.
    DRAFT P01. GenDx Reagents SOW FY25.pdf
    The Iowa City VA Health Care System is seeking contractors to provide next generation sequencing (NGS) reagent kits compatible with the Illumina MiSeq instrument, under a firm fixed-price, Indefinite Delivery-Indefinite Quantity (IDIQ) contract. The purpose is to facilitate the identification of human leukocyte antigen alleles through specific amplifications. The contract emphasizes adherence to performance standards set by the Clinical Laboratory Improvement Act (CLIA) and Clinical and Laboratory Standards Institute (CLSI). Key specifications include the requirement for quality control testing by the manufacturer, acceptance of products by the Contracting Officer’s Representative, and the obligation to replace defective products at no cost within 48 business hours. Additionally, the contractor must promptly inform the VA of product recalls or safety issues. Deliveries will be accepted on weekdays, excluding federal holidays. This initiative underscores the VA's commitment to maintaining high standards in laboratory operations while ensuring availability of essential reagents for patient testing and research.
    Lifecycle
    Title
    Type
    6515--Request for Information Name Brand GENDX Reagent Or Equal
    Currently viewing
    Sources Sought
    Similar Opportunities
    6640--BD MAX REAGENTS STL
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to provide molecular testing and extraction supplies for the BD MAX instrument at the St. Louis VA Medical Center. This procurement involves a Firm Fixed Price Blanket Purchase Agreement (BPA) for specific reagents necessary for nucleic acid detection and extraction, with an estimated contract duration of one base year and four optional yearly ordering periods, commencing from November 1, 2024, to October 31, 2029. The supplies are critical for ensuring uninterrupted patient care operations, and interested parties, particularly Service-Disabled Veteran Owned Small Businesses, must submit their responses by September 20, 2024, to Contract Specialist Michael P. Murphy at michael.murphy7@va.gov. The government does not guarantee any contract awards based on this notice, which serves solely for market research purposes.
    6515--FY25: Automated Nucleic Acid Extraction System
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to provide an Automated Nucleic Acid Extraction System as part of a Sources Sought Notice under solicitation number 36C24824Q1656. The system must be fully automated, capable of efficiently extracting high-quality DNA and RNA from various specimen types, including formalin-fixed paraffin embedded tissues, while demonstrating superiority in extraction methods for next-generation sequencing applications. This procurement is crucial for enhancing laboratory capabilities within the VA, ensuring high throughput processing and compatibility with multiple extraction kits, all while adhering to standard laboratory benchtop dimensions. Interested parties must submit their responses, including company information and a capability statement, by September 24, 2024, to Contract Specialist Benjamin Amato at benjamin.amato@va.gov.
    6550--VISN Multiplex PCR Testing Reagents/Consumables Intent to sole source
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Great Lakes Acquisition Center, intends to negotiate a sole source contract with BioMerieux, Inc. for the provision of proprietary reagents and consumables necessary for PCR testing on government-owned devices across facilities in Wisconsin, Illinois, and Michigan. This procurement is essential to ensure that the VA can maintain high-quality healthcare services, as only BioMerieux is deemed capable of meeting the specialized requirements for these supplies. The contract will be established as a Blanket Purchase Agreement (BPA) under an existing contract, categorized as firm fixed price, and is being conducted in accordance with FAR 8.405-6. Interested firms must submit their qualifications and relevant customer references to the Contracting Officer, Teresa Beers, at teresa.beers@va.gov within seven calendar days from the publication date of this notice, as no competitive proposals will be solicited.
    6550--VISN 6 BioFire FilmArray Verification Kits.
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to negotiate a sole source contract for the procurement of BioFire FilmArray Verification Kits from Biomerieux, Inc., to meet the specialized needs of the Veterans Integrated Service Network (VISN) 6. The contract will include various diagnostic panels, with specific quantities required for each type, ensuring that the VA can provide timely and effective medical services to veterans. This procurement is critical as these specialized diagnostic supplies are only available from a single source, emphasizing the importance of maintaining compliance with federal regulations and the efficient delivery of healthcare services. Interested firms may express their capabilities to the Contract Specialist, LaToya Glover, via email by September 23, 2024, with the contract expected to be awarded effective October 1, 2024.
    6515--Viscoelastic Testing Instrumentation
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking potential vendors capable of providing viscoelastic testing instrumentation for the Richmond VA Medical Center in Virginia. The procurement includes a comprehensive viscoelastic testing instrument system that must perform clinical parameter analyses on whole blood specimens, interface with existing VA laboratory middleware systems, and comply with the performance standards set by the Clinical Laboratory Improvement Act and the Clinical and Laboratory Standards Institute. Interested vendors are required to submit their qualifications, including business size classification and relevant certifications, by 10:00 AM EST on September 20, 2024, to Jo Ann Harris, Contract Specialist, at Jo.Harris@va.gov. This opportunity emphasizes the VA's commitment to prioritizing Service-Disabled Veteran-Owned and Veteran-Owned Small Businesses in the procurement process.
    6640--Electrophoresis Testing VA VISN2
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified small businesses to provide electrophoresis testing services under an Indefinite Delivery contract for its Upstate New York Medical Center Laboratories located in Albany, Buffalo, and Syracuse. The contract will cover various types of electrophoresis testing, including Serum Protein Electrophoresis (SPEP), Urine Protein Electrophoresis (UPEP), Immuno-Fixation Electrophoresis (IFE), and Cerebral Spinal Fluid (CSF)/Oligoclonal Bands, which are critical for diagnosing conditions such as Multiple Myeloma and Multiple Sclerosis. The contract period is set from October 1, 2024, to September 30, 2029, with a submission deadline for quotes by 4:00 PM on September 23, 2024. Interested parties should direct inquiries to Contract Specialist Sam A DeMuzio at sam.demuzio@va.gov or call (585) 393-7735.
    Q301--Coagulation CPT
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking information through a Sources Sought Notice for coagulation testing services across various locations within the VISN 22 network. The objective is to identify potential qualified suppliers capable of providing a Cost Per Test (CPT) framework for coagulation testing, ensuring compliance with clinical and regulatory standards, and maintaining operational efficiency. This procurement is critical for supporting the healthcare needs of veterans, with a performance period anticipated to span a base year plus four optional years. Interested vendors must submit their responses, including business status and capabilities, by September 27, 2024, to Clift Domen at Clift.Domen@va.gov.
    6515--Nucleic Acid Purification System - Research, Ann Arbor
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs intends to negotiate a sole source contract for a Nucleic Acid Purification System for the LTC Charles S. Kettles VA Medical Center in Ann Arbor, MI. This procurement will be executed under Simplified Acquisition Procedures, citing FAR Part 6.302-1, as the government believes that only Fisher Scientific possesses the necessary capabilities to fulfill this requirement. The Nucleic Acid Purification System is critical for medical research and diagnostics, ensuring high-quality results in nucleic acid extraction processes. Interested parties should note that the response deadline is September 23, 2024, by 4 PM Eastern Time, and inquiries can be directed to Contracting Officer James Howard at james.howard3@va.gov.
    6550--ALBAcyte Red Blood Cell Reagents-Notice of Intent to Sole Source
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 10, intends to negotiate a sole source contract for ALBAcyte Red Blood Cell Reagents with Alba Bioscience Inc. This procurement is essential for the Blood Bank Department at the Richard L. Roudebush VA Medical Center, as it involves specialized reagents necessary for blood typing and compatibility testing critical for patient transfusions. The urgency of this acquisition is underscored by the unique quality of the reagents from Alba Bioscience, which eliminates the need for repeated validations from other sources. Responses to this notice must be submitted by 2:00 pm EST on September 23, 2024, to Contract Specialist Lonnelle Jones at lonnelle.jones@va.gov, as no solicitation package will be provided.
    Next-Generation Sequencing (NGS) Liquid Handling Systems – Brand Name or Equal
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for two Next-Generation Sequencing (NGS) Liquid Handling Systems to enhance research capabilities at its Bethesda, Maryland campus. These systems are essential for high-throughput processing in infectious disease research, particularly for single cell-based antibody discovery and RNA/DNA processing, which are critical for pandemic preparedness. Interested vendors must submit their quotes by 12:00 pm EST on September 26, 2024, including detailed specifications and compliance with federal regulations, to Daveta H. Brown at daveta.brown@nih.gov.